The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media-Related Antibiotic Use among Young Children in Tennessee, USA

2Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Otitis media (OM) is a leading cause of pediatric antibiotic use. Introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) led to reductions in OM among US children, though its impact on OM-related antibiotic use remains unclear. Among 499 683 Tennessee children <2 years of age, the OM-related antibiotic fill rate was stable after PCV13 introduction.

Cite

CITATION STYLE

APA

Griffith, H., Wiese, A. D., Mitchel, E. F., & Grijalva, C. G. (2022). The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media-Related Antibiotic Use among Young Children in Tennessee, USA. Open Forum Infectious Diseases, 9(3). https://doi.org/10.1093/ofid/ofac019

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free